Related Experiment Video
Updated: Jun 23, 2026

Gastrointestinal Motility Monitor (GIMM)
Published on: December 2, 2010
Plasma motilin concentration and interdigestive migrating motor complex in diabetic gastroparesis: effect of
Abstract:
The objective of this study is to determine whether abnormal rhythm and amplitude of the oscillation in plasma motilin concentration are responsible for the abnormal motility observed in patients with diabetic gastroparesis. We also investigated the effect of metoclopramide on plasma motilin concentration and gastrointestinal motility in these patients. In healthy controls, basal plasma motilin concentration fluctuated in phase with the interdigestive migrating motor complex. All patients with diabetic gastroparesis did not have antral phase III activities and had significantly higher basal motilin concentrations, which maintained a normal oscillatory pattern. Administration of metoclopramide initiated antral phase III activities in healthy controls and in patients with diabetic gastroparesis. These were accompanied by a concurrent rise in plasma motilin concentration in healthy controls, contrasting with a fall in plasma motilin concentrations in patients with diabetic gastroparesis. We conclude that diabetic gastroparesis is associated with absence of antral interdigestive migrating motor complex and with elevated plasma motilin concentration with normal cyclic fluctuations. Our studies also show that metoclopramide initiates antral phase III activities in diabetic gastroparesis independent of plasma motilin concentration.
Insights
Diabetic gastroparesis is linked to absent gut motility patterns and high motilin levels. Metoclopramide restores motility in these patients, irrespective of motilin concentration changes.
Area of Science:
- Gastroenterology
- Endocrinology
- Pharmacology
Background:
- Diabetic gastroparesis is characterized by abnormal gastrointestinal motility.
- The role of plasma motilin concentration oscillations in this condition is not fully understood.
Purpose of the Study:
- To investigate if abnormal plasma motilin oscillations cause motility issues in diabetic gastroparesis.
- To examine metoclopramide's effects on plasma motilin and gastrointestinal motility in these patients.
Main Methods:
- Measured plasma motilin concentration and gastrointestinal motility in healthy controls and diabetic gastroparesis patients.
- Administered metoclopramide to assess its impact on motility and motilin levels.
Main Results:
- Diabetic gastroparesis patients lacked normal interdigestive migrating motor complex (phase III activity).
- Patients exhibited higher basal motilin concentrations with normal fluctuations.
- Metoclopramide induced phase III activity in both groups, but motilin levels decreased in patients versus increased in controls.
Conclusions:
- Diabetic gastroparesis involves absent antral interdigestive migrating motor complex and elevated, but normally fluctuating, plasma motilin.
- Metoclopramide effectively initiates gastrointestinal motility in diabetic gastroparesis independently of plasma motilin levels.
More Related Videos
Related Concept Videos
Gastrointestinal Motility Disorders
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Intestinal Phase of Digestion
The arrival of the chyme in the small intestine distends the duodenum, which triggers the enterogastric reflex. This distension...
Gastric Motility
Peristaltic Waves and Chyme Formation
Upon food entry, the stomach initiates...
Imaging Studies III: Gastrointestinal Motility Studies and Virtual Colonoscopy
Radionuclide Testing
Radionuclide testing is a sophisticated medical technique for assessing gastrointestinal motility. It focuses on gastric emptying and colonic transit time. Radioactive markers track the movement of food through the digestive system, providing insights into gastrointestinal disorders.
In gastric emptying studies, a meal's liquid and solid...
![Assessment of Gastric Emptying in Non-obese Diabetic Mice Using a [13C]-octanoic Acid Breath Test](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F50301.jpg&w=3840&q=50)
